Advertisement
Screener

Biofrontera Inc. (BFRI) Form D

Biofrontera Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2025-07-11: Federal exemption Rule 506(b); Types of securities offered Equity; Series C Convertible Preferred Stock; Date of first sale 2025-06-27; Total offering amount $11,000,000.
  • 2024-12-05: Federal exemption Rule 506(b); Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2024-11-21; Total offering amount $4,200,000.
  • 2024-03-05: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2024-02-19; Total offering amount $8,000,000.
  • 2022-08-11: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2022-07-27; Total offering amount $7,114,287.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2025-07-11Rule 506(b)Equity; Series C Convertible Preferred Stock2025-06-27$11,000,000$11,000,000$05
2024-12-05Rule 506(b)Debt; SecurityToBeAcquired2024-11-21$4,200,000$4,200,000$05
2024-03-05Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2024-02-19$8,000,000$8,000,000$08
2022-08-11Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2022-07-27$7,114,287$7,114,287$01
2022-05-23Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2022-05-16$9,400,681$9,400,681$01
2021-12-10Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2021-11-29$15,000,000$15,000,000$01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Korsana Biosciences, Inc. (CYCN)United States$0.016B